Skip to main content
. 2023 Nov 4;9(11):e21505. doi: 10.1016/j.heliyon.2023.e21505

Fig. 6.

Fig. 6

(A) aged ≤60 years subgroup, OS in different TMSB4X expressions (B) adenocarcinoma subgroup, OS in different TMSB4X expressions (C) N1 stage subgroup, OS in different TMSB4X expressions (D) stage II subgroup, OS in different TMSB4X expressions.